209 related articles for article (PubMed ID: 29972178)
1. Enhanced and preferential internalization of lipid nanocapsules into human glioblastoma cells: effect of a surface-functionalizing NFL peptide.
Karim R; Lepeltier E; Esnault L; Pigeon P; Lemaire L; Lépinoux-Chambaud C; Clere N; Jaouen G; Eyer J; Piel G; Passirani C
Nanoscale; 2018 Jul; 10(28):13485-13501. PubMed ID: 29972178
[TBL] [Abstract][Full Text] [Related]
2. Characterization and quantification of the interaction between the NFL-TBS.40-63 peptide and lipid nanocapsules.
Griveau A; Alnemeh-Al Ali H; Jourdain MA; Dupont A; Eyer J
Int J Pharm X; 2022 Dec; 4():100127. PubMed ID: 36177093
[TBL] [Abstract][Full Text] [Related]
3. Glioblastoma-targeted, local and sustained drug delivery system based on an unconventional lipid nanocapsule hydrogel.
Gazaille C; Bozzato E; Madadian-Bozorg N; Mellinger A; Sicot M; Farooq U; Saulnier P; Eyer J; Préat V; Bertrand N; Bastiat G
Biomater Adv; 2023 Oct; 153():213549. PubMed ID: 37453243
[TBL] [Abstract][Full Text] [Related]
4. The effect of functionalizing lipid nanocapsules with NFL-TBS.40-63 peptide on their uptake by glioblastoma cells.
Balzeau J; Pinier M; Berges R; Saulnier P; Benoit JP; Eyer J
Biomaterials; 2013 Apr; 34(13):3381-9. PubMed ID: 23391494
[TBL] [Abstract][Full Text] [Related]
5. Characterization of Biological Material Adsorption to the Surface of Nanoparticles without a Prior Separation Step: a Case Study of Glioblastoma-Targeting Peptide and Lipid Nanocapsules.
Gazaille C; Sicot M; Akiki M; Lautram N; Dupont A; Saulnier P; Eyer J; Bastiat G
Pharm Res; 2021 Apr; 38(4):681-691. PubMed ID: 33829340
[TBL] [Abstract][Full Text] [Related]
6. Development of multifunctional lipid nanocapsules for the co-delivery of paclitaxel and CpG-ODN in the treatment of glioblastoma.
Lollo G; Vincent M; Ullio-Gamboa G; Lemaire L; Franconi F; Couez D; Benoit JP
Int J Pharm; 2015 Nov; 495(2):972-80. PubMed ID: 26428632
[TBL] [Abstract][Full Text] [Related]
7. Development and characterization of sorafenib-loaded lipid nanocapsules for the treatment of glioblastoma.
Clavreul A; Roger E; Pourbaghi-Masouleh M; Lemaire L; Tétaud C; Menei P
Drug Deliv; 2018 Nov; 25(1):1756-1765. PubMed ID: 30338715
[TBL] [Abstract][Full Text] [Related]
8. Tumour targeting of lipid nanocapsules grafted with cRGD peptides.
Hirsjärvi S; Belloche C; Hindré F; Garcion E; Benoit JP
Eur J Pharm Biopharm; 2014 May; 87(1):152-9. PubMed ID: 24361535
[TBL] [Abstract][Full Text] [Related]
9. Ferrociphenol lipid nanocapsule delivery by mesenchymal stromal cells in brain tumor therapy.
Roger M; Clavreul A; Huynh NT; Passirani C; Schiller P; Vessières A; Montero-Menei C; Menei P
Int J Pharm; 2012 Feb; 423(1):63-8. PubMed ID: 21554935
[TBL] [Abstract][Full Text] [Related]
10. Locoregional Confinement and Major Clinical Benefit of
Séhédic D; Chourpa I; Tétaud C; Griveau A; Loussouarn C; Avril S; Legendre C; Lepareur N; Wion D; Hindré F; Davodeau F; Garcion E
Theranostics; 2017; 7(18):4517-4536. PubMed ID: 29158842
[TBL] [Abstract][Full Text] [Related]
11. Anticancer properties of lipid and poly(ε-caprolactone) nanocapsules loaded with ferrocenyl-tamoxifen derivatives.
Najlaoui F; Pigeon P; Aroui S; Pezet M; Sancey L; Marrakchi N; Rhouma A; Jaouen G; De Waard M; Busser B; Gibaud S
J Pharm Pharmacol; 2018 Nov; 70(11):1474-1484. PubMed ID: 30141195
[TBL] [Abstract][Full Text] [Related]
12. Inter-nanocarrier and nanocarrier-to-cell transfer assays demonstrate the risk of an immediate unloading of dye from labeled lipid nanocapsules.
Simonsson C; Bastiat G; Pitorre M; Klymchenko AS; Béjaud J; Mély Y; Benoit JP
Eur J Pharm Biopharm; 2016 Jan; 98():47-56. PubMed ID: 26522878
[TBL] [Abstract][Full Text] [Related]
13. Targeting of immunosuppressive myeloid cells from glioblastoma patients by modulation of size and surface charge of lipid nanocapsules.
Pinton L; Magri S; Masetto E; Vettore M; Schibuola I; Ingangi V; Marigo I; Matha K; Benoit JP; Della Puppa A; Bronte V; Lollo G; Mandruzzato S
J Nanobiotechnology; 2020 Feb; 18(1):31. PubMed ID: 32066449
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of the effectiveness of poly(ε-caprolactone) lipid-core nanocapsules loaded with methotrexate on glioblastoma multiforme treatment.
Pereira NRC; Loiola RA; Rodrigues SF; de Oliveira CP; Büttenbender SL; Guterres SS; Pohlmann AR; Farsky SH
Int J Nanomedicine; 2018; 13():4563-4573. PubMed ID: 30154652
[TBL] [Abstract][Full Text] [Related]
15. Targeting and treatment of glioblastomas with human mesenchymal stem cells carrying ferrociphenol lipid nanocapsules.
Clavreul A; Montagu A; Lainé AL; Tétaud C; Lautram N; Franconi F; Passirani C; Vessières A; Montero-Menei CN; Menei P
Int J Nanomedicine; 2015; 10():1259-71. PubMed ID: 25709447
[TBL] [Abstract][Full Text] [Related]
16. Efficient ferrocifen anticancer drug and Bcl-2 gene therapy using lipid nanocapsules on human melanoma xenograft in mouse.
Resnier P; Galopin N; Sibiril Y; Clavreul A; Cayon J; Briganti A; Legras P; Vessières A; Montier T; Jaouen G; Benoit JP; Passirani C
Pharmacol Res; 2017 Dec; 126():54-65. PubMed ID: 28159700
[TBL] [Abstract][Full Text] [Related]
17. Lipid-Core Nanocapsules Act as a Drug Shuttle Through the Blood Brain Barrier and Reduce Glioblastoma After Intravenous or Oral Administration.
Rodrigues SF; Fiel LA; Shimada AL; Pereira NR; Guterres SS; Pohlmann AR; Farsky SH
J Biomed Nanotechnol; 2016 May; 12(5):986-1000. PubMed ID: 27305820
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the distribution, retention, and efficacy of internal radiation of
Cikankowitz A; Clavreul A; Tétaud C; Lemaire L; Rousseau A; Lepareur N; Dabli D; Bouchet F; Garcion E; Menei P; Couturier O; Hindré F
J Neurooncol; 2017 Jan; 131(1):49-58. PubMed ID: 27783195
[TBL] [Abstract][Full Text] [Related]
19. Influence of size, surface coating and fine chemical composition on the in vitro reactivity and in vivo biodistribution of lipid nanocapsules versus lipid nanoemulsions in cancer models.
Hirsjärvi S; Dufort S; Gravier J; Texier I; Yan Q; Bibette J; Sancey L; Josserand V; Passirani C; Benoit JP; Coll JL
Nanomedicine; 2013 Apr; 9(3):375-87. PubMed ID: 22960195
[TBL] [Abstract][Full Text] [Related]
20. Lipid nanocapsules decorated and loaded with cannabidiol as targeted prolonged release carriers for glioma therapy: In vitro screening of critical parameters.
Aparicio-Blanco J; Sebastián V; Benoit JP; Torres-Suárez AI
Eur J Pharm Biopharm; 2019 Jan; 134():126-137. PubMed ID: 30472144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
